130 related articles for article (PubMed ID: 10649594)
1. In vitro percutaneous absorption of fusidic acid and betamethasone 17-valerate across canine skin.
Degim IT; Hadgraft J; Houghton E; Teale P
J Small Anim Pract; 1999 Nov; 40(11):515-8. PubMed ID: 10649594
[TBL] [Abstract][Full Text] [Related]
2. Betamethasone valerate foam 0.12%: a novel vehicle with enhanced delivery and efficacy.
Franz TJ; Parsell DA; Halualani RM; Hannigan JF; Kalbach JP; Harkonen WS
Int J Dermatol; 1999 Aug; 38(8):628-32. PubMed ID: 10487457
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of measuring lipophilic or protein-bound drugs in the dermis by in vivo microdialysis after topical or systemic drug administration.
Benfeldt E; Groth L
Acta Derm Venereol; 1998 Jul; 78(4):274-8. PubMed ID: 9689295
[TBL] [Abstract][Full Text] [Related]
4. Topical fusidic acid/betamethasone-containing gel compared to systemic therapy in the treatment of canine acute moist dermatitis.
Cobb MA; Edwards HJ; Jagger TD; Marshall J; Bowker KE
Vet J; 2005 Mar; 169(2):276-80. PubMed ID: 15727921
[TBL] [Abstract][Full Text] [Related]
5. Opportunities for topical antimicrobial therapy: permeation of canine skin by fusidic acid.
Frosini SM; Bond R; Loeffler A; Larner J
BMC Vet Res; 2017 Nov; 13(1):345. PubMed ID: 29162115
[TBL] [Abstract][Full Text] [Related]
6. Fusidic acid betamethasone lipid cream.
Girolomoni G; Mattina R; Manfredini S; Vertuani S; Fabrizi G
Int J Clin Pract; 2016 May; 70 Suppl 184():4-13. PubMed ID: 27121235
[TBL] [Abstract][Full Text] [Related]
7. Preclinical Assessment of Steroidal Nanostructured Lipid Carriers Based Gels for Atopic Dermatitis: Optimization and Product Development.
Nagaich U; Gulati N
Curr Drug Deliv; 2018; 15(5):641-651. PubMed ID: 28925874
[TBL] [Abstract][Full Text] [Related]
8. Comparison of PLGA and lecithin/chitosan nanoparticles for dermal targeting of betamethasone valerate.
Özcan I; Azizoğlu E; Senyiğit T; Özyazici M; Özer Ö
J Drug Target; 2013 Jul; 21(6):542-50. PubMed ID: 23390922
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous diffusion and metabolism of betamethasone 17-valerate in the living skin equivalent.
Kubota K; Ademola J; Maibach HI
J Pharm Sci; 1995 Dec; 84(12):1478-81. PubMed ID: 8748331
[TBL] [Abstract][Full Text] [Related]
10. Impact of synthetic canine cerumen on in vitro penetration of auricular skin of dogs by florfenicol, terbinafine, and betamethasone acetate.
Ehling S; Baynes RE; Bäumer W
Am J Vet Res; 2018 Mar; 79(3):333-341. PubMed ID: 29466046
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous metabolism and penetration of methoxypsoralen, betamethasone 17-valerate, retinoic acid, nitroglycerin and theophylline.
Ademola JI; Maibach HI
Curr Probl Dermatol; 1995; 22():201-13. PubMed ID: 7587326
[No Abstract] [Full Text] [Related]
12. Metabolism of topical drugs within the skin, in particular glucocorticoids.
Kubota K; Ademola J; Maibach HI
Curr Probl Dermatol; 1993; 21():61-6. PubMed ID: 8299377
[No Abstract] [Full Text] [Related]
13. Percutaneous permeation of betamethasone 17-valerate incorporated in lipid nanoparticles.
Zhang J; Smith E
J Pharm Sci; 2011 Mar; 100(3):896-903. PubMed ID: 20839362
[TBL] [Abstract][Full Text] [Related]
14. Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin.
Gysler A; Kleuser B; Sippl W; Lange K; Korting HC; Höltje HD; Korting HC
Pharm Res; 1999 Sep; 16(9):1386-91. PubMed ID: 10496654
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a novel stability-indicating HPLC method for the simultaneous assay of betamethasone-17-valerate, fusidic acid, potassium sorbate, methylparaben and propylparaben in a topical cream preparation.
Byrne J; Velasco-Torrijos T; Reinhardt R
J Pharm Biomed Anal; 2014 Aug; 96():111-7. PubMed ID: 24731970
[TBL] [Abstract][Full Text] [Related]
16. Spectrophotometric methods for simultaneous determination of betamethasone valerate and fusidic acid in their binary mixture.
Lotfy HM; Salem H; Abdelkawy M; Samir A
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Apr; 140():294-304. PubMed ID: 25615682
[TBL] [Abstract][Full Text] [Related]
17. Formulation factors affecting the isomerization rate of betamethasone-17-valerate in a developmental hydrophilic cream - a HPLC and microscopy based stability study.
Byrne J; Wyraz A; Velasco-Torrijos T; Reinhardt R
Pharm Dev Technol; 2017 Jun; 22(4):537-544. PubMed ID: 26895450
[TBL] [Abstract][Full Text] [Related]
18. Relationship between in vivo skin blanching and in vitro release rate for betamethasone valerate creams.
Shah VP; Elkins J; Skelly JP
J Pharm Sci; 1992 Jan; 81(1):104-6. PubMed ID: 1619561
[TBL] [Abstract][Full Text] [Related]
19. Penetration and permeation into human skin of fusidic acid in different galenical formulation.
Stüttgen G; Bauer E
Arzneimittelforschung; 1988 May; 38(5):730-5. PubMed ID: 3415719
[TBL] [Abstract][Full Text] [Related]
20. Palm Olein Emulsion: a Novel Vehicle for Topical Drug Delivery of Betamethasone 17-Valerate.
Ahmad K; Win T; Jaffri JM; Edueng K; Taher M
AAPS PharmSciTech; 2018 Jan; 19(1):371-383. PubMed ID: 28744617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
